References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. doi:10.3322/caac.21590
- Hurvitz SA, Hu Y, O’Brien N, Finn RS. Current approaches and future directions in the treatment of HER2-positive breast cancer. Cancer Treat Rev. 2013;39:219–229. doi:10.1016/j.ctrv.2012.04.008
- Sun X, Wang Z, Chen X, Shen K. CRISPR-cas9 screening identified lethal genes enriched in cell cycle pathway and of prognosis significance in breast cancer. Front Cell Dev Biol. 2021;9:646774. doi:10.3389/fcell.2021.646774
- Merrill RA, Ahrens JM, Kaiser ME, Federhart KS, Poon VY, Clagett-Dame M. All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos. Biol Chem. 2004;385:605–614. doi:10.1515/BC.2004.075
- Marzinke MA, Henderson EM, Yang KS, See AW, Knutson DC, Clagett-Dame M. Calmin expression in embryos and the adult brain, and its regulation by all-trans retinoic acid. Dev Dyn. 2010;239:610–619. doi:10.1002/dvdy.22171
- Takaishi M, Ishisaki Z, Yoshida T, Takata Y, Huh NH. Expression of calmin, a novel developmentally regulated brain protein with calponin-homology domains. Brain Res Mol Brain Res. 2003;112:146–152. doi:10.1016/S0169-328X(03)00061-5
- Sheng L, Anderson PH, Turner AG, et al. Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016;164:90–97. doi:10.1016/j.jsbmb.2015.10.012
- Simmons KM, Beaudin SG, Narvaez CJ, Welsh J. Gene signatures of 1,25-Dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem. 2015;116:1693–1711. doi:10.1002/jcb.25129
- Yanatatsaneejit P, Chalermchai T, Kerekhanjanarong V, et al. Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. Oral Oncol. 2008;44:400–406. doi:10.1016/j.oraloncology.2007.05.008
- Badal K, Ali R, Warner WA, et al. Factors associated with breast cancer recurrence and survival at Sangre Grande Hospital, Trinidad. Cancer Causes Control. 2021;32(7):763–772. doi:10.1007/s10552-021-01427-z
- Cao TQ, Dixit K, Santa-Maria C, Kumthekar P. Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: a large single-institutional analysis with potential screening implications. Neurooncol Adv. 2021;3:vdab009.
- Marzinke MA, Clagett-Dame M. The all-trans retinoic acid (atRA)-regulated gene Calmin (Clmn) regulates cell cycle exit and neurite outgrowth in murine neuroblastoma (Neuro2a) cells. Exp Cell Res. 2012;318:85–93. doi:10.1016/j.yexcr.2011.10.002
- Poplawski P, Piekielko-Witkowska A, Nauman A. The significance of TRIP11 and T3 signalling pathway in renal cancer progression and survival of patients. Endokrynol Pol. 2017;68:631–641.
- Huang S, Chong N, Lewis NE, Jia W, Xie G, Garmire LX. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis. Genome Med. 2016;8:34. doi:10.1186/s13073-016-0289-9
- Luo X, Yu H, Song Y, Sun T. Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival. J Cell Physiol. 2019;234:13021–13031. doi:10.1002/jcp.27973
- Vethakanraj HS, Babu TA, Sudarsanan GB, Duraisamy PK, Ashok Kumar S. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines. Biochem Biophys Res Commun. 2015;464:833–839. doi:10.1016/j.bbrc.2015.07.047